skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 17,853  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Combination anti-HIV antibodies provide sustained virological suppression
Combination anti-HIV antibodies provide sustained virological suppression
Material Type:
Article 		Add to My Research

Combination anti-HIV antibodies provide sustained virological suppression

Nature (London), 2022-06, Vol.606 (7913), p.375-381 [Peer Reviewed Journal]

2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;Copyright Nature Publishing Group Jun 9, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04797-9 ;PMID: 35650437

Full text available

Citations Cited by
2
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Material Type:
Article 		Add to My Research

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

Cell, 2020-07, Vol.182 (1), p.73-84.e16 [Peer Reviewed Journal]

2020 ;Copyright © 2020. Published by Elsevier Inc. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Published by Elsevier Inc. 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.05.025 ;PMID: 32425270

Digital Resources/Online E-Resources

Citations Cited by
3
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Material Type:
Article 		Add to My Research

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Nature (London), 2020-12, Vol.588 (7839), p.682-687 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Dec 24-Dec 31, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2852-1 ;PMID: 33045718

Full text available

Citations Cited by
4
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Material Type:
Article 		Add to My Research

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Nature (London), 2020-08, Vol.584 (7821), p.450-456 [Peer Reviewed Journal]

Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2571-7 ;PMID: 32698192

Full text available

Citations Cited by
5
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Material Type:
Article 		Add to My Research

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Science, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd0827

Digital Resources/Online E-Resources

Citations Cited by
6
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

Nature (London), 2021-12, Vol.600 (7889), p.530-535 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Dec 16, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04117-7 ;PMID: 34670266

Full text available

Citations Cited by
7
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Material Type:
Article 		Add to My Research

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Science, 2020-08, Vol.369 (6504) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc6952

Digital Resources/Online E-Resources

Citations Cited by
8
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Material Type:
Article 		Add to My Research

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Science, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc7520

Digital Resources/Online E-Resources

Citations Cited by
9
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Cell Reports, 2022-05, Vol.39 (7), p.110812-110812, Article 110812 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Authors 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.110812 ;PMID: 35568025

Digital Resources/Online E-Resources

Citations Cited by
10
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Material Type:
Article 		Add to My Research

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Nature (London), 2015-06, Vol.522 (7557), p.487-491 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14411 ;PMID: 25855300 ;CODEN: NATUAS

Full text available

Citations Cited by
11
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Material Type:
Article 		Add to My Research

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Nature (London), 2018-09, Vol.561 (7724), p.479-484 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Sep 27, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-018-0531-2 ;PMID: 30258136

Full text available

Citations Cited by
12
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Material Type:
Article 		Add to My Research

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Trends in Immunology, 2020-05, Vol.41 (5), p.355 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.it.2020.03.007

Digital Resources/Online E-Resources

Citations Cited by
13
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage
Material Type:
Article 		Add to My Research

VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage

Cell host & microbe, 2020-04, Vol.27 (4), p.531-543.e6 [Peer Reviewed Journal]

2020 ;Published by Elsevier Inc. ;ISSN: 1931-3128 ;ISSN: 1934-6069 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.01.027 ;PMID: 32130953

Full text available

Citations Cited by
14
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Material Type:
Article 		Add to My Research

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Cell, 2020-11, Vol.183 (4), p.1024-1042.e21 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.09.037 ;PMID: 32991844

Digital Resources/Online E-Resources

Citations Cited by
15
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
Material Type:
Article 		Add to My Research

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows

Nature (London), 2017-08, Vol.548 (7665), p.108-111 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Aug 3, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature23301 ;PMID: 28726771

Full text available

Citations Cited by
16
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
Material Type:
Article 		Add to My Research

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization

Proceedings of the National Academy of Sciences - PNAS, 2022-03, Vol.119 (11), p.e2122954119-e2122954119 [Peer Reviewed Journal]

Copyright National Academy of Sciences Mar 15, 2022 ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2122954119 ;PMID: 35238654

Full text available

Citations Cited by
17
Development of an inactivated vaccine candidate for SARS-CoV-2
Development of an inactivated vaccine candidate for SARS-CoV-2
Material Type:
Article 		Add to My Research

Development of an inactivated vaccine candidate for SARS-CoV-2

Science, 2020-07, Vol.369 (6499) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc1932

Digital Resources/Online E-Resources

Citations Cited by
18
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Material Type:
Article 		Add to My Research

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Science, 2020-06, Vol.368 (6496) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc2241

Digital Resources/Online E-Resources

Citations Cited by
19
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Nature (London), 2021-07, Vol.595 (7869), p.718-723 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jul 29, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03673-2 ;PMID: 34082438

Full text available

Citations Cited by
20
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Material Type:
Article 		Add to My Research

Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques

Nature (London), 2019-06, Vol.570 (7762), p.468-473 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jun 27, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1250-z ;PMID: 31142836

Full text available

Citations Cited by

Results 1 - 20 of 17,853  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (16,949)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1963  (163)
  2. 1963 To 1977  (159)
  3. 1978 To 1992  (395)
  4. 1993 To 2008  (1,095)
  5. After 2008  (16,027)
  6. More options open sub menu

Subject 

  1. Science & Technology  (15,790)
  2. Life Sciences & Biomedicine  (13,461)
  3. Humans  (10,527)
  4. Animals  (7,907)
  5. Immunology  (6,068)
  6. Antibodies  (5,741)
  7. Vaccines  (5,114)
  8. Antibodies, Neutralizing - Immunology  (4,970)
  9. Female  (4,526)
  10. Viruses  (4,021)
  11. Mice  (3,987)
  12. Virology  (3,730)
  13. Infections  (3,565)
  14. Microbiology  (3,459)
  15. Male  (3,194)
  16. Antibodies, Neutralizing - Blood  (3,172)
  17. Proteins  (3,059)
  18. Infectious Diseases  (3,052)
  19. Covid-19  (2,990)
  20. Sars-Cov-2  (2,951)
  21. More options open sub menu

Language 

  1. English  (17,711)
  2. Japanese  (2,596)
  3. Portuguese  (61)
  4. French  (47)
  5. Russian  (41)
  6. Chinese  (32)
  7. German  (30)
  8. Spanish  (25)
  9. Norwegian  (19)
  10. Korean  (5)
  11. Polish  (3)
  12. Persian  (3)
  13. Turkish  (2)
  14. Dutch  (2)
  15. Czech  (1)
  16. Latvian  (1)
  17. Italian  (1)
  18. Ukrainian  (1)
  19. Croatian  (1)
  20. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait